Indian Gooseberry (Phyllanthus emblica), commonly known as Amla, has a long history of use in traditional Ayurvedic medicine for supporting cardiovascular health, described as "heart weakness" in classical texts. Modern scientific research has begun to validate some of these traditional claims. Several preclinical and clinical studies suggest that Amla possesses cardioprotective properties. Its high content of vitamin C, polyphenols, and flavonoids contributes to potent antioxidant effects, which may help reduce oxidative stress—a key factor in cardiovascular disease.

Human studies, though limited in scale, have shown that Amla supplementation can lower total cholesterol, LDL cholesterol, and triglycerides while raising HDL cholesterol. Additionally, some trials report modest reductions in blood pressure. For example, a 2012 randomized clinical trial found that Amla extract improved lipid profiles in patients with hyperlipidemia. Animal studies have also demonstrated protective effects against chemically induced heart damage, likely due to its antioxidative and anti-inflammatory activities.

While these findings are promising and suggest a scientific basis for Amla's use in supporting cardiovascular health, the evidence is not yet robust. Most clinical trials are small and of short duration, and more large-scale, long-term studies are needed to confirm efficacy and establish safety profiles. Nonetheless, current research provides moderate scientific support for the traditional use of Indian Gooseberry in maintaining heart health.